3//SEC Filing
PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC 3
Accession 0001104659-18-047104
CIK 0001330436operating
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 8:52 PM ET
Size
14.2 KB
Accession
0001104659-18-047104
Insider Transaction Report
Form 3
Holdings
Series C Preferred Stock
→ Common Stock (442,819 underlying)
Eagle Holding Co I
10% Owner
Holdings
Series C Preferred Stock
→ Common Stock (442,819 underlying)
Jaguar Holding Co I, LLC
10% Owner
Holdings
Series C Preferred Stock
→ Common Stock (442,819 underlying)
Eagle Holding Co II, LLC
10% Owner
Holdings
Series C Preferred Stock
→ Common Stock (442,819 underlying)
Holdings
Series C Preferred Stock
→ Common Stock (442,819 underlying)
Jaguar Holding Co II
10% Owner
Holdings
Series C Preferred Stock
→ Common Stock (442,819 underlying)
Footnotes (3)
- [F1]All shares of Series C Preferred Stock, par value $0.001 per share, have no expiration date and will automatically convert into the Issuer's common stock on approximately a 0.1295-for-1 basis immediately prior to the closing of the initial public offering.
- [F2]These securities are held of record by Pharmaceutical Product Development, LLC ("Pharma LLC"). Wildcat Acquisition Holdings (UK) Limited ("Wildcat") is the sole member of Pharma LLC; Jaguar Holding Company II ("Jaguar II") is the sole shareholder of Wildcat; Jaguar Holding Company I, LLC ("Jaguar I") is the sole shareholder of Jaguar II; Eagle Holding Company II, LLC ("Eagle II") is the sole member of Jaguar I; and Eagle Holding Company I is the sole member of Eagle II. By virtue of such relationships, each of the reporting persons may be deemed to have beneficial ownership over such securities.
- [F3]This report on Form 3 is jointly filed by the reporting persons. Each of the reporting persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. This report shall not be deemed an admission that any of the reporting persons is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes.
Documents
Issuer
Liquidia Technologies Inc
CIK 0001330436
Entity typeoperating
IncorporatedNC
Related Parties
1- filerCIK 0001003124
Filing Metadata
- Form type
- 3
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 8:52 PM ET
- Size
- 14.2 KB